A randomized trial of ex vivo CD40L activation of a dendritic cell vaccine in colorectal cancer patients: tumor-specific immune responses are associated with improved survival (Q34365990)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
A randomized trial of ex vivo CD40L activation of a dendritic cell vaccine in colorectal cancer patients: tumor-specific immune responses are associated with improved survival
scientific article

    Statements

    A randomized trial of ex vivo CD40L activation of a dendritic cell vaccine in colorectal cancer patients: tumor-specific immune responses are associated with improved survival (English)
    Richard J Barth
    Dawn A Fisher
    Paul K Wallace
    Jacqueline Y Channon
    Randolph J Noelle
    Marc S Ernstoff
    30 September 2010
    5548-5556

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit